These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36055578)

  • 21. Human islet amyloid polypeptide accumulates at similar sites in islets of transgenic mice and humans.
    de Koning EJ; Höppener JW; Verbeek JS; Oosterwijk C; van Hulst KL; Baker CA; Lips CJ; Morris JF; Clark A
    Diabetes; 1994 May; 43(5):640-4. PubMed ID: 8168639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro.
    Hull RL; Zraika S; Udayasankar J; Kisilevsky R; Szarek WA; Wight TN; Kahn SE
    Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1586-93. PubMed ID: 17804609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes.
    Andrikopoulos S; Verchere CB; Terauchi Y; Kadowaki T; Kahn SE
    Diabetes; 2000 Dec; 49(12):2056-62. PubMed ID: 11118007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus.
    Höppener JW; Jacobs HM; Wierup N; Sotthewes G; Sprong M; de Vos P; Berger R; Sundler F; Ahrén B
    Exp Diabetes Res; 2008; 2008():697035. PubMed ID: 18497871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo.
    Mo XD; Gao LP; Wang QJ; Yin J; Jing YH
    Lipids Health Dis; 2018 Mar; 17(1):42. PubMed ID: 29523142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neprilysin impedes islet amyloid formation by inhibition of fibril formation rather than peptide degradation.
    Zraika S; Aston-Mourney K; Marek P; Hull RL; Green PS; Udayasankar J; Subramanian SL; Raleigh DP; Kahn SE
    J Biol Chem; 2010 Jun; 285(24):18177-83. PubMed ID: 20400513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer's disease.
    Capsoni S; Carlo AS; Vignone D; Amato G; Criscuolo C; Willnow TE; Cattaneo A
    J Alzheimers Dis; 2013; 33(2):357-71. PubMed ID: 22986780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small interfering RNA-mediated suppression of proislet amyloid polypeptide expression inhibits islet amyloid formation and enhances survival of human islets in culture.
    Marzban L; Tomas A; Becker TC; Rosenberg L; Oberholzer J; Fraser PE; Halban PA; Verchere CB
    Diabetes; 2008 Nov; 57(11):3045-55. PubMed ID: 18694973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The S20G substitution in hIAPP is more amyloidogenic and cytotoxic than wild-type hIAPP in mouse islets.
    Meier DT; Entrup L; Templin AT; Hogan MF; Mellati M; Zraika S; Hull RL; Kahn SE
    Diabetologia; 2016 Oct; 59(10):2166-71. PubMed ID: 27393137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
    O'Brien TD; Butler PC; Westermark P; Johnson KH
    Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid-induced β-cell dysfunction and islet inflammation are ameliorated by 4-phenylbutyrate (PBA) treatment.
    Montane J; de Pablo S; Castaño C; Rodríguez-Comas J; Cadavez L; Obach M; Visa M; Alcarraz-Vizán G; Sanchez-Martinez M; Nonell-Canals A; Parrizas M; Servitja JM; Novials A
    FASEB J; 2017 Dec; 31(12):5296-5306. PubMed ID: 28821639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death.
    Marzban L; Rhodes CJ; Steiner DF; Haataja L; Halban PA; Verchere CB
    Diabetes; 2006 Aug; 55(8):2192-201. PubMed ID: 16873681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets.
    Subramanian SL; Hull RL; Zraika S; Aston-Mourney K; Udayasankar J; Kahn SE
    Diabetologia; 2012 Jan; 55(1):166-74. PubMed ID: 22038516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional proteasome complex is required for turnover of islet amyloid polypeptide in pancreatic β-cells.
    Chatterjee Bhowmick D; Jeremic A
    J Biol Chem; 2018 Sep; 293(37):14210-14223. PubMed ID: 30012886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RIPK3 promotes islet amyloid-induced β-cell loss and glucose intolerance in a humanized mouse model of type 2 diabetes.
    Mukherjee N; Contreras CJ; Lin L; Colglazier KA; Mather EG; Kalwat MA; Esser N; Kahn SE; Templin AT
    Mol Metab; 2024 Feb; 80():101877. PubMed ID: 38218538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophages and pancreatic islet amyloidosis.
    de Koning EJ; van den Brand JJ; Mott VL; Chargé SB; Hansen BC; Bodkin NL; Morris JF; Clark A
    Amyloid; 1998 Dec; 5(4):247-54. PubMed ID: 10036582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of glycosaminoglycan-mediated amyloid formation by islet amyloid polypeptide and proIAPP processing intermediates.
    Meng F; Raleigh DP
    J Mol Biol; 2011 Feb; 406(3):491-502. PubMed ID: 21195086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Islet amyloid development in a mouse strain lacking endogenous islet amyloid polypeptide (IAPP) but expressing human IAPP.
    Westermark GT; Gebre-Medhin S; Steiner DF; Westermark P
    Mol Med; 2000 Dec; 6(12):998-1007. PubMed ID: 11474116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pro islet amyloid polypeptide (ProIAPP) immunoreactivity in the islets of Langerhans.
    Westermark GT; Steiner DF; Gebre-Medhin S; Engström U; Westermark P
    Ups J Med Sci; 2000; 105(2):97-106. PubMed ID: 11095107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells.
    Oskarsson ME; Hermansson E; Wang Y; Welsh N; Presto J; Johansson J; Westermark GT
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2752-E2761. PubMed ID: 29507232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.